Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

Recruiting now · Not applicable

Conditions studied: Renal Carcinoma

In brief

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.

Key facts

Study ID

NCT06290427

Run by

Azienda Ospedaliera Universitaria Integrata Verona

People needed

30

Starts

2024-02-01

Expected to finish

2025-06-01

Last updated by the study team

2025-01-03

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patient aged between 18 and 90 years old;
• patient with localized kidney tumor suitable for partial nephrectomy;
• patient able to understand and sign the informed consent;
• patient compliance with the follow-up program.

You may not qualify if…

• patient who do not fall within the inclusion age range;
• patient not suitable for partial nephrectomy;
• patient unable to understand and sign the informed consent;
• patient unable to follow the monitoring program;
• patient refusal to participate to the study.

Where it is running

• Urology Unit, AOUI Verona — Verona, VR, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.